- Science
- Global
Stealth switch in tuberculosis enzyme could open route to drug-resistant treatment
- May 1, 2026 at 7:00 PM
- 5 views
Recent research published in Communications Biology marks an advance in structural biology by enhancing understanding of protein regulation mechanisms in Mycobacterium tuberculosis (Mtb), a global health threat. The team led by the University of Melbourne combined several advanced techniques at the Australian Synchrotron and the National Deuteration Facility to reveal the hidden allosteric mechanism that activates a key enzyme, ICL2.
Originally published at Phys.org